[
    [
        {
            "time": "2023-10-05",
            "original_text": "GSK vs. NVO: Which Stock Is the Better Value Option?",
            "features": {
                "keywords": [
                    "GSK",
                    "NVO",
                    "value option"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "GSK vs. NVO: Which Stock Is the Better Value Option?",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Novo Nordisk Shares Slump As Wegovy Hits US Supply Issues; Deutsche Bank Downgrades",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "Wegovy",
                    "US supply issues",
                    "Deutsche Bank",
                    "downgrades"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Novo Nordisk Shares Slump As Wegovy Hits US Supply Issues; Deutsche Bank Downgrades",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Novo Nordisk shares tank after key drug hope hit by U.S. supply issues",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "drug",
                    "U.S. supply issues"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Novo Nordisk shares tank after key drug hope hit by U.S. supply issues",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Moderna, AT&T Rise Premarket; United Airlines, Tesla, Exxon Mobil Fall",
            "features": {
                "keywords": [
                    "Moderna",
                    "AT&T",
                    "United Airlines",
                    "Tesla",
                    "Exxon Mobil"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology",
                    "energy",
                    "transportation"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "Moderna, AT&T Rise Premarket; United Airlines, Tesla, Exxon Mobil Fall",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Novo Nordisk Tumbles as Contractor Issues Hit U.S. Obesity Drug Supply",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "contractor issues",
                    "U.S. obesity drug supply"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Novo Nordisk Tumbles as Contractor Issues Hit U.S. Obesity Drug Supply",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]